Jump to content

Clazakizumab

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Rod57 (talk | contribs) at 00:51, 11 November 2009 (start). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

ALD518 a humanized monclonal antibody against interleukin-6.

Clinical trials

Cancer

Phase II trial for advanced cancer.[1]

Rheumatoid arthritis

Phase II trial for rheumatoid arthritis.[2]

References